Based on there unreal fundamentals IMO why is AEZS so cheap. Reminds me on QCOR back in 2009
It reminds me of when I bought QCOR several years back when it was trading near $1 and it too had nice revs, minimal debt and low multiple. QCOR is in the $50s but was in the $70's this year. AEZS trades around 4.5 times earnings, zero debt, around $25 mln cash on hand. $77mln in revs, quarterly rev growth of 195 percent and I can go on and on. This doesnt even take into account its pipeline of additional drugs. What am I missing here.